Radium Ra 223 With Enzalutamide in Men With Metastatic Castration Refractory Prostate Cancer

Trial Profile

Radium Ra 223 With Enzalutamide in Men With Metastatic Castration Refractory Prostate Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Enzalutamide (Primary) ; Radium 223 chloride
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Sep 2015 Planned number of patients changed from 35 to 50 as reported by ClinicalTrials.gov
    • 31 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top